cross-neutralization

cross-neutralization

[¦krȯs ‚nü·trə·lə′zā·shən]
(electronics)
Method of neutralization used in push-pull amplifiers, whereby a portion of the plate-cathode alternating-current voltage of each vacuum tube is applied to the grid-cathode circuit of the other vacuum tube through a neutralizing capacitor.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera.
This and other studies have underscored a widespread pattern of cross-neutralization of antivenoms against heterologous Bothrops sp.
These differences may contribute to the distinct pattern of MAb binding and to differences in cross-neutralization between BoHV-1 and BoHV-5 (17).
Brunet, "Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo," Vaccine, vol.
Finally, the predicted recognition of W437 by e20 and e137 does not limit their cross-recognition and cross-neutralization profile of different genotypes/isolates as conversely observed by Duan et al.
(http://dx.doi.org/10.1038/nature11414) "Cross-neutralization of influenza A viruses mediated by a single antibody loop." Nature published online 16 September 2012.
This report (("A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease" in Journal of Feline Medicne and Surgery, 2010)) describes the ability of a vaccine containing two different strains of FCV to induce protection in vaccinated animals against many strains of the virus.
Several groups have recently revealed that chimeric VLP in which the cross-neutralization epitope of L2 inserted induce cross-neutralizing antibodies more effectively (27,28).
Weiss told SCIENCE NEWS that this cross-neutralization offers hope that broad-spectrum drugs may be effective against the changeable HIV-1 virus, which, like the influenza virus, is notorious for its rapid mutation rate (SN: 6/28/86, p.410).
However, we have previously observed no evidence of PeV-A3 cross-neutralization by polyclonal and monoclonal antibodies elicited against PeV-A1 to 5 (14,15).
Studies shown that no antibody against ONN was produced eliminating the possibility of 2-way cross-neutralization test between CHIK and ONN viruses (11,12).